Blueprint Medicines Corp 3/A SEC Filings

Filed On	Filing
31 Mar 2022	Form 3/A: Beckman Daniella, Director No securities owned
28 Mar 2016	Form 3/A: Lengauer Christoph, Chief Scientific Officer Holds 188,332 shares of Common Stock
01 May 2015	Form 3/A: Lengauer Christoph, Chief Scientific Officer Holds 188,332 shares of Common Stock

Comments